Seth Fischer
Director/Board Member at AGILE THERAPEUTICS, INC.
Net worth: 68 609 $ as of 31/03/2024
Profile
Seth H.
Z.
Fischer is currently serving as an Independent Director at Marinus Pharmaceuticals, Inc., Lead Independent Director at Agile Therapeutics, Inc., Director at Esperion Therapeutics, Inc., and Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. He is also an Advisor at Healthquest Capital Management Co LLC.
In his former positions, Mr. Fischer served as the Chief Executive Officer & Director at VIVUS, Inc., Group Chairman at Biosense Webster, Inc., Group Chairman at Janssen Pharmaceuticals, Inc., Group Chairman at North American Pharmaceuticals Co., Chairman-Worldwide Franchise at Cordis Corp., and Group Chairman at Johnson & Johnson.
He also held positions as Group Chairman at Scios, Inc., Chairman & President at Ortho-McNeil Pharmaceutical LLC, Director at BioSig Technologies, Inc., Director at Trius Therapeutics, Inc., and Director at Spectrum Pharmaceuticals, Inc.Mr. Fischer obtained his undergraduate degree from The Ohio University in 1977.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 01/04/2024 | 6,026 ( 0.01% ) | 54 475 $ | 31/03/2024 | |
| 15/06/2023 | 5,150 ( 0.00% ) | 13 802 $ | 31/03/2024 | |
AGILE THERAPEUTICS, INC.
0.01% | 08/06/2023 | 976 ( 0.01% ) | 332 $ | 31/03/2024 |
| 07/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Seth Fischer active positions
| Companies | Position | Start |
|---|---|---|
| AGILE THERAPEUTICS, INC. | Director/Board Member | 28/07/2016 |
| MARINUS PHARMACEUTICALS, INC. | Director/Board Member | 06/09/2016 |
| ESPERION THERAPEUTICS, INC. | Director/Board Member | 28/10/2021 |
| MILESTONE PHARMACEUTICALS INC. | Director/Board Member | 21/03/2023 |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Consultant / Advisor | - |
Former positions of Seth Fischer
| Companies | Position | End |
|---|---|---|
| SPECTRUM PHARMACEUTICALS, INC. | Director/Board Member | 31/07/2023 |
| BIOSIG TECHNOLOGIES, INC. | Director/Board Member | 17/05/2019 |
| VIVUS, INC. | Chief Executive Officer | 31/12/2017 |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Director/Board Member | 11/09/2013 |
| ░░░░░░░░ ░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
Training of Seth Fischer
| The Ohio University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 7 |
|---|---|
| JOHNSON & JOHNSON | Health Technology |
| SPECTRUM PHARMACEUTICALS, INC. | Health Technology |
| ESPERION THERAPEUTICS, INC. | Health Technology |
| AGILE THERAPEUTICS, INC. | Health Technology |
| MARINUS PHARMACEUTICALS, INC. | Health Technology |
| MILESTONE PHARMACEUTICALS INC. | Health Technology |
| BIOSIG TECHNOLOGIES, INC. | Health Technology |
| Private companies | 9 |
|---|---|
Cordis Corp.
 Cordis Corp. Medical SpecialtiesHealth Technology Cordis Corp. develops and manufactures devices for interventional vascular medicine and electrophysiology. The firm's products include guidewires, balloons, forceps, catheters, and stents to treat a variety of circulatory system problems including coronary artery disease and cerebral aneurysms. The company was founded by William P. Murphy Jr. in 1959 and is headquartered in Milpitas, CA. | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Scios Inc. developed, manufactured, and commercialized pharmaceuticals for conditions such as cardiovascular and inflammatory diseases. The company was founded in 1981 and was headquartered in Sunnyvale, CA. | Health Technology |
VIVUS, Inc.
 VIVUS, Inc. Pharmaceuticals: MajorHealth Technology VIVUS, Inc. engaged in the development and commercialization of novel therapeutic products. The firm’s products were indicated for the treatment of obese and overweight patients, exocrine pancreatic insufficiency, and erectile dysfunction. Its products include PANCREAZE, Qsymia, and STENDRA/SPEDRA. The company was founded by Virgil A. Place in April 16, 1991 and it was headquartered in Campbell, CA. | Health Technology |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Health Technology |
Ortho-McNeil Pharmaceutical LLC
 Ortho-McNeil Pharmaceutical LLC Pharmaceuticals: MajorHealth Technology Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ. | Health Technology |
Biosense Webster, Inc.
 Biosense Webster, Inc. Medical SpecialtiesHealth Technology Biosense Webster, Inc. develops technology solutions for diagnosing heart rhythm disorders. It provides deflectable tip catheter for treating arrhythmia disorder. The company was founded by Wilton W. Webster Jr. and Shlomo Ben-Haim in 1998 and is headquartered in South Diamond Bar, CA. | Health Technology |
Trius Therapeutics, Inc.
Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Trius Therapeutics, Inc. is a biopharmaceutical company which focuses on the discovery, development and commercialization of innovative antibiotics for life-threatening infections. It engages in developing tedizolid phosphate an intravenous, or IV, and oral antibiotic, for the treatment of serious gram-positive bacterial infections, initially for acute bacterial skin and skin structure infections, ABSSSI, and subsequently for other indications, including pneumonia. ABSSSI is a new classification for complicated skin and skin structure infections, or cSSSI. Tedizolid phosphate is an IV and orally administered second generation oxazolidinone. The company develops antibiotics for gram-negative infections. Trius Therapeutics was founded by John Finn and John P. Schmid in June 2004, and is headquartered in San Diego, CA. | Health Technology |
| North American Pharmaceuticals Co. | |
Healthquest Capital Management Co LLC
Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital Management Co LLC (HealthQuest Capital ) is a private equity firm founded in 2013 by Garheng Kong. The firm is headquartered in Redwood City, California. | Finance |
- Stock Market
- Insiders
- Seth Fischer
